Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  GlycoMimetics, Inc.    GLYC

GLYCOMIMETICS, INC.

(GLYC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GLYCOMIMETICS, INC.
2020GLYCOMIMETICS : New Supportive Efficacy Data for GlycoMimetics' Rivipansel in Si..
BU
2020GLYCOMIMETICS : Uproleselan in Combination with Venetoclax HMA Shown to Break Ch..
AQ
2020GLYCOMIMETICS : ' Uproleselan in Combination With Venetoclax/HMA Shown to Break ..
BU
2020GLYCOMIMETICS : to Present at Two Upcoming Virtual Healthcare Investor Conferenc..
AQ
2020GLYCOMIMETICS : to Present at Two Upcoming Virtual Healthcare Investor Conferenc..
BU
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Third Quarter 2020
AQ
2020GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta..
AQ
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Third Quarter 2020
BU
2020GLYCOMIMETICS : 3Q Earnings Snapshot
AQ
2020GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2020GLYCOMIMETICS : Program Data to be Highlighted Via Three Oral Presentations and ..
BU
2020GLYCOMIMETICS : to Report Third Quarter Financial Results on November 6, 2020
AQ
2020GLYCOMIMETICS : to Report Third Quarter Financial Results on November 6, 2020
BU
2020GLYCOMIMETICS : New Pediatric and Secondary Endpoint Data from Rivipansel Phase ..
AQ
2020GLYCOMIMETICS : New Pediatric and Secondary Endpoint Data from Rivipansel Phase ..
BU
2020GLYCOMIMETICS INC : Entry into a Material Definitive Agreement, Financial Statem..
AQ
2020GLYCOMIMETICS : FDA Grants GlycoMimetics Rare Pediatric Disease Designation for ..
AQ
2020GLYCOMIMETICS : FDA Grants GlycoMimetics Rare Pediatric Disease Designation for ..
BU
2020GLYCOMIMETICS : Apollomics, Inc. Receives China Investigational New Drug Approva..
AQ
2020GLYCOMIMETICS : to Present at Upcoming H.C. Wainwright & Co Annual Global Invest..
BU
2020GLYCOMIMETICS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BU
2020GLYCOMIMETICS : New Preclinical GlycoMimetics Data Suggests Uproleselan With Ven..
AQ
2020GLYCOMIMETICS : New Preclinical GlycoMimetics Data Suggests Uproleselan With Ven..
BU
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Second Quarter 2020
AQ
2020GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta..
AQ
2020GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2020GLYCOMIMETICS : 2Q Earnings Snapshot
AQ
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Second Quarter 2020
BU
2020GLYCOMIMETICS : to Report Second Quarter Financial Results on July 31, 2020
AQ
2020GLYCOMIMETICS : to Report Second Quarter Financial Results on July 31, 2020
BU
2020GLYCOMIMETICS : Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
BU
2020GLYCOMIMETICS : New Efficacy and Biomarker Data from Rivipansel Phase 3 RESET tr..
AQ
2020GLYCOMIMETICS : New Efficacy and Biomarker Data From Rivipansel Phase 3 RESET Tr..
BU
2020GLYCOMIMETICS : to Present at Upcoming Jefferies Virtual Healthcare Conference
AQ
2020GLYCOMIMETICS : to Present at Upcoming Jefferies Virtual Healthcare Conference
BU
2020GLYCOMIMETICS INC : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2020GLYCOMIMETICS : to Present New Preclinical Data Highlighting Biomarkers and Pote..
AQ
2020GLYCOMIMETICS : to Present New Preclinical Data Highlighting Biomarkers and Pote..
BU
2020GLYCOMIMETICS : Announces Change to Virtual Meeting Format for 2020 Annual Meeti..
AQ
2020GLYCOMIMETICS : Announces Change to Virtual Meeting Format for 2020 Annual Meeti..
BU
2020GLYCOMIMETICS : Reports Operational Highlights and Financial Results for First Q..
AQ
2020GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta..
AQ
2020GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2020GLYCOMIMETICS : 1Q Earnings Snapshot
AQ
2020GLYCOMIMETICS : Reports Operational Highlights and Financial Results for First Q..
BU
2020GLYCOMIMETICS : Compelling Data on Mechanism of Action for GlycoMimetics Late-st..
AQ
2020GLYCOMIMETICS : Compelling Data on Mechanism of Action for GlycoMimetics' Late-s..
BU
2020GLYCOMIMETICS : to Report First Quarter Financial Results on May 1, 2020
AQ
2020GLYCOMIMETICS : to Report First Quarter Financial Results on May 1, 2020
BU
2020GLYCOMIMETICS : Appoints Dr. Myra Rosario Herrle as Vice President, Regulatory A..
BU
2020GLYCOMIMETICS : Reports Inducement Grant under NASDAQ Listing Rule 5635(4)
AQ
2020GLYCOMIMETICS : Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
BU
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Fourth Quarter and ..
AQ
2020GLYCOMIMETICS INC : Results of Operations and Financial Condition, Other Events,..
AQ
2020GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2020GLYCOMIMETICS : 4Q Earnings Snapshot
AQ
2020GLYCOMIMETICS : Reports Highlights and Financial Results for Fourth Quarter and ..
BU
2020GLYCOMIMETICS : to Present at the Cowen and Company 40th Annual Health Care Conf..
BU
2020GLYCOMIMETICS INC : Termination of a Material Definitive Agreement (form 8-K)
AQ
2020GLYCOMIMETICS : Advances GMI-1359 Program With Patent Issuance and FDA Designati..
BU
2020GLYCOMIMETICS : First Patient with Advanced Breast Cancer Receives First Dose in..
AQ
2020GLYCOMIMETICS : First Patient With Advanced Breast Cancer Receives First Dose in..
BU
2020GLYCOMIMETICS INC : Entry into a Material Definitive Agreement, Regulation FD Di..
AQ
2020GLYCOMIMETICS : and Apollomics Announce Exclusive Collaboration and License Agre..
BU
2019GLYCOMIMETICS : to Present at the Piper Jaffrey 31st Annual Healthcare Conferenc..
AQ
2019GLYCOMIMETICS : to Present at the Piper Jaffrey 31st Annual Healthcare Conferenc..
BU
2019GLYCOMIMETICS INC : Regulation FD Disclosure (form 8-K)
AQ
2019GLYCOMIMETICS : to Present at Two Upcoming Investor Conferences
BU
2019GLYCOMIMETICS : Reports Third Quarter 2019 Financial Results and Recent Operatio..
BU
2019GLYCOMIMETICS : to Present Further Analysis of Data From Phase 1/2 AML Trial of ..
BU
2019GLYCOMIMETICS : to Report Third Quarter 2019 Financial Results on November 7, 20..
BU
2019GLYCOMIMETICS : to Present at Two Upcoming Investor Conferences
BU
2019GLYCOMIMETICS : Reports Top-line Results From Pfizer's Phase 3 Clinical Trial Ev..
PU
2019GLYCOMIMETICS : Reports Top-line Results From Pfizer's Phase 3 Clinical Trial Ev..
BU
2019GLYCOMIMETICS : Reports Second Quarter 2019 Financial Results and Recent Operati..
BU
1  2  3  4Next
Upcoming event on GLYCOMIMETICS, INC.